A novel treatment for weight reduction by the recombinant "Pichia pastoris" yeast expressing the hybrid protein of "irisin-furin-transferrin"

Journal of Integrative Medicine
Mahsa JaliliAzita Hekmatdoost

Abstract

Obesity is a major health problem across the world, but there are few ways to effectively treat or manage it in the long term. Researchers are searching for more convenient, cost-effective and noninvasive therapies for overweight and obese people. Recent studies have illustrated that the microbiome of the body's different organs can be used as a vehicle for in-situ gene therapy. We suggest that the recombinant form of "Pichia pastoris" yeast expressing the hybrid protein of "irisin-furin-transferrin" under the control of the enolase 1 promoter is a new nutraceutical strategy to absorb fewer calories from intestinal nutrients, and induce a higher metabolic rate to expend more calories, similar to that from engaging in physical activity. By comparison, this method can be a long-term, noninvasive treatment and can be used for obese patients who have movement limitations.

References

Apr 22, 2003·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·William J H Griffiths, Timothy M Cox
May 5, 2005·Proceedings of the National Academy of Sciences of the United States of America·Yun BaiWei-Chiang Shen
Feb 24, 2007·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·P Kopelman
Jan 2, 2008·The Journal of Experimental Medicine·Tamara Matysiak-BudnikMartine Heyman
Dec 31, 2009·Applied Microbiology and Biotechnology·Lisa du PlessisWillem H van Zyl
Apr 1, 2010·Nutrients·Saloomeh Moslehi-JenabianLene Jespersen
Apr 5, 2012·ISRN Endocrinology·Wai W Cheung, Peizhong Mao
Jan 2, 2014·Indian Journal of Clinical Biochemistry : IJCB·Rajni Dawar Mahajan, Surajeet Kumar Patra
May 13, 2014·Current Obesity Reports·Brian A IrvingGeorge Argyropoulos
Jun 11, 2014·Annals of Medicine·Cristina ContrerasMiguel López

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.